Financials
- Market Capitalization 17.3 B
- Employee 2 000
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
20.27
주가매출액비율
4.35
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 510 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.41 USD | -0.49% | -2.09% | +4.59% | +15.69% | 25.56 B USD | ||
| 613 | VTRS Viatris Inc. - Common Stock | 16.31 USD | -0.49% | -3.72% | +0.37% | +57.58% | 18.99 B USD | ||
| 780 | ELAN Elanco Animal Health Incorporated Common Stock | 25.55 USD | +1.59% | +4.76% | +5.23% | +14.09% | 12.76 B USD | ||
| 877 | RDY Dr. Reddy's Laboratories Ltd | 12.84 USD | -0.62% | -12.35% | -3.09% | -11.87% | 10.72 B USD |